alpha galactosidase A (IMAPPROT)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namealpha galactosidase A (IMAPPROT)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of Actionα-Galactosidase stimulants
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioingenium, SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVtt Technical Research Centre Of FinlandUniversita degli Studi di Napoli Federico IIBioingenium, SL +[6] 
Active IndicationsN/A
Inactive IndicationsFabry Disease

Other Information

ATC CodeN/A
Related LinksN/A